Sil Kordes

Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial

Sil Kordes, Michaël Pollak, Aeilko H. Zwinderman et al. · The Lancet Oncology · 2015 · 372 citations

Placebo-controlled Phase 2, Oncology, Pancreatic Cancer +8

Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer

Sil Kordes, Heinz‐Josef Klümpen, Mariëtte J. Weterman et al. · Cancer Chemotherapy and Pharmacology · 2015 · 67 citations · Full text

A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer

Sil Kordes, Dick J. Richel, Heinz‐Josef Klümpen et al. · Investigational New Drugs · 2012 · 35 citations · Full text

Preoperative Chemoradiation Therapy in Combination With Panitumumab for Patients With Resectable Esophageal Cancer: The PACT Study

Sil Kordes, Mark I. van Berge Henegouwen, Maarten C.C.M. Hulshof et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 25 citations

Surgical Oncology, Esophagus, Esophageal Cancer +11

A phase II randomized, placebo controlled study to evaluate the efficacy of the combination of gemcitabine, erlotinib, and metformin in patients with locally advanced or metastatic pancreatic cancer.

Johanna W. Wilmink, Sil Kordes, Koos Zwinderman et al. · Journal of Clinical Oncology · 2014 · 10 citations

Placebo Arm, Oncology, Pancreatic Cancer +9